22.9 C
New York

Tag: Health care industry

Black academic Jason Arday, who resigned from the...

Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial failed to reduce major...

Here are 4 forces that drove a tough week for stocks

It was a tough week for stocks, as investors navigated everything from escalating tensions in the Middle East to key tech earnings reports to...

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's announcement that Eli Lilly will acquire AtaiBeckley, a...

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle. Keeping it off long...

Jim Cramer says these are the 5 stocks to buy during this market rotation

CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's creating buying opportunities in several high-quality stocks...

Jim Cramer says this former Covid market darling is finally investable again

Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate...

Chan Zuckerberg Initiative’s Biohub to open new rare disease funding round

Priscilla Chan (R) and her husband Mark Zuckerberg announce the Chan Zuckerberg Initiative to "cure, prevent or manage all disease" by the end of...

UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency

Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy for Huntington's disease, the...

Centene to offer buyouts to some employees as health insurer cuts costs

Sheldon Cooper | Lightrocket | Getty ImagesCentene said it offered buyouts to some employees on Monday, as the health insurer grapples with higher medical...

Healthy Returns: CVS Health executives on reducing healthcare’s biggest pain points

Nikolas Kokovlis | Nurphoto | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news...

Food supply ‘not at risk’ after new Texas screwworm cases, USDA secretary says

The U.S. food supply is "not at risk" from the return of the flesh-eating screwworm ​parasite to Texas, U.S. Department of Agriculture Secretary Brooke...

Recent articles

spot_img